Entering text into the input field will update the search result below

Tracking ValueAct Portfolio - Q4 2022 Update

Mar. 07, 2023 9:12 PM ETAMPS, BLD, C, C.PJ, C.PK, CBRE, CRM, FISV, KKR, LKQ, NSIT, NTDOF, NTDOY, NYT, RKT, STX2 Comments
John Vincent profile picture
John Vincent
23.15K Followers

Summary

  • ValueAct’s 13F portfolio value decreased from $5.90B to $5.31B this quarter.
  • ValueAct increased New York Times while dropping Citigroup and TopBuild.
  • The top three positions are Fiserv, KKR, and CBRE, and they add up to ~62% of the portfolio.

Move forward, overcoming an obstacle. On contrary, opposite, One not like other, Contrarian, be against the trend and be non-conformist

welcomeinside

This article is part of a series that provides an ongoing analysis of the changes made to ValueAct's 13F stock portfolio on a quarterly basis. It is based on their regulatory 13F Form filed on 2/14/2023. Please visit our

Jeffrey Ubben - ValueAct's Q4 2022 13F Report Q/Q Comparison

Jeffrey Ubben - ValueAct's Q4 2022 13F Report Q/Q Comparison (John Vincent (author))

This article was written by

John Vincent profile picture
23.15K Followers
Focused on analyzing 13F reports & building tools to help DIY investors generate absolute returns through exploiting inefficiency, volatility, and momentum.

Analyst’s Disclosure: I/we have a beneficial long position in the shares of C either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.